Methods and compositions for expressing a heterologous protease

Details for Australian Patent Application No. 2006262380 (hide)

Owner MedImmune Vaccines, Inc.

Inventors Young, James; Duke, Gregory; Mo, Chengjun; Kemble, George; Hazari, Nisha

Agent Phillips Ormonde Fitzpatrick

Pub. Number AU-A-2006262380

PCT Pub. Number WO2007/002007

Priority 60/699,556 15.07.05 US; 60/699,555 15.07.05 US; 60/692,965 21.06.05 US; 60/793,522 19.04.06 US; 60/793,525 19.04.06 US; 60/692,978 21.06.05 US; 60/702,006 22.07.05 US

Filing date 20 June 2006

Wipo publication date 4 January 2007

International Classifications

C12N 9/00 (2006.01) Enzymes, e.g. ligases (6.)

Event Publications

31 January 2008 PCT application entered the National Phase

  PCT publication WO2007/002007 Priority application(s): WO2007/002007

2 October 2008 Alteration of Name

  The name of the applicant has been altered to MedImmune, LLC

19 January 2012 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(d). Examination has been requested or an examination report has issued for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2006262381-Methods and compositions for expressing negative-sense viral RNA in canine cells

2006262378-Lower ash lubricating oil with low cold cranking simulator viscosity